gliclazide has been researched along with Arteriosclerosis in 10 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gliclazide is an oral sulfonylurea agent that has been reported to have actions on platelet function and fibrinolysis in addition to its effects on glycemia." | 2.38 | Pathophysiology of vascular disease in diabetes: effects of gliclazide. ( Colwell, JA, 1991) |
| "Gliclazide treatment lowered LPS-stimulated TNF-alpha production by diabetic monocytes to levels similar to those observed in control subjects." | 1.30 | Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment. ( Desfaits, AC; Renier, G; Serri, O, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Renier, G | 2 |
| Mamputu, JC | 1 |
| Serri, O | 2 |
| Matsumoto, K | 1 |
| Sera, Y | 1 |
| Abe, Y | 1 |
| Tominaga, T | 1 |
| Yeki, Y | 1 |
| Miyake, S | 1 |
| Desfaits, AC | 1 |
| Nomura, H | 1 |
| Naito, M | 1 |
| Kodama, M | 1 |
| Kato, Y | 1 |
| Iguchi, A | 1 |
| Marquié, G | 2 |
| Brindley, DN | 1 |
| Gram, J | 1 |
| Jespersen, J | 1 |
| Colwell, JA | 1 |
| Lesobre, B | 1 |
5 reviews available for gliclazide and Arteriosclerosis
| Article | Year |
|---|---|
Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells.
Topics: Animals; Aorta; Arteriosclerosis; Cell Adhesion; Endothelium, Vascular; Gliclazide; Glycation End Pr | 2003 |
Metabolic approach to atherosclerosis: effect of gliclazide.
Topics: Animals; Arteriosclerosis; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Glicla | 1992 |
Increased fibrinolytic potential induced by gliclazide in type I and type II diabetic patients.
Topics: Arteriosclerosis; Diabetes Mellitus; Diabetic Angiopathies; Fibrinolysis; Gliclazide; Humans | 1992 |
Pathophysiology of vascular disease in diabetes: effects of gliclazide.
Topics: Arteriosclerosis; Blood Platelets; Diabetic Angiopathies; Endothelium, Vascular; Gliclazide; Humans | 1991 |
[Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
Topics: Animals; Arteriosclerosis; Blood Platelets; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Endoth | 1990 |
5 other studies available for gliclazide and Arteriosclerosis
| Article | Year |
|---|---|
Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes.
Topics: Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Chronic Disease; Diabetes Mellitus, Typ | 2004 |
Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor-alpha production in NIDDM patients after gliclazide treatment.
Topics: Animals; Aorta; Arteriosclerosis; Cattle; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; C | 1998 |
Effects of gliclazide on low-density lipoprotein oxidizability and atherosclerosis in cholesterol-fed rabbits.
Topics: Animals; Arteriosclerosis; Blood Glucose; Cholesterol, Dietary; Eating; Gliclazide; Hypoglycemic Age | 2000 |
[Preventive effects of gliclazide on the development of cholesterol induced atherosclerosis in rabbits].
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Cholesterol Esters; Cholesterol, Dieta | 1977 |
Preventive effect of gliclazide on experimental atherosclerosis in rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol, Dietary; Diet, Atherogenic; Disease Models, Animal; F | 1978 |